Injection of lyophilized Candida albicans or C. parapsilosis cells induced amyloidosis in outbred CFW mice. The disease process was irreversible, and a significant number of animals died of systemic amyloidosis within 400 days after the last treatment. The techniques described may represent a model system for the study of systemic amyloidosis.
Amyloidosis has been studied for over a century, but its etiology remains unknown. Amyloid deposits can occur spontaneously in many different species of animals or can be induced by a wide range of materials such as repeated inoculation with casein, bacteria, egg albumen, turpentine, or endotoxin from Escherichia coli (1, 2, (5) (6) (7) (8) 10) . Experimentally induced amyloidosis in laboratory animals may gradually regress or disappear from one or more organs once the causal agent is removed (5, 6, 11, 13) .
Recently, Pearsall and Lagunoff (9) reported that amyloidosis occurred in the majority of treated mice of one inbred strain at 2 weeks after a single injection of Candida albicans or Saccharomyces cerevisiae cells. A lower incidence of amyloidosis occurred in several other strains, usually later than 2 weeks after treatment. The results of the present study are in agreement with these findings (9); injections of C. albicans and C. parapsilosis cells into outbred mice induced amyloidosis. Moreover, our study showed that the disease process was irreversible. A highly significant number of animals died of systemic amyloidosis within 400 days after the last treatment.
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RESULTS
Most animals with amyloidosis could be recognized prior to becoming moribund; the body was often turgid and the eyes had a pale glassy appearance. Frequently, animals were either edematous or ascitic or both. Blood smears from moribund animals showed an increase in the number of leukocytes. The spleens were abnormal, the liver mottled, and the cortical surface of the kidneys of many animals was pale, blotchy, and diffusely granular. Moderate to severe adhesions often occurred between various organs or between an organ and the parietal peritoneum.
Deposits of amyloid were recognized readily in the spleens (Fig. 1 ) and kidneys. Most animals had deposits in the liver (Fig. 2) . In severely afflicted animals, amyloid was observed in the majority of internal organs including heart and lung. Often, most of the normal structure of the spleen and liver was replaced by amyloid ( Fig. 1 and 2 Experimental amyloidosis in laboratory animals may regress or disappear from one or more organs once the causal agent is removed (5, 6, 11, 13) . The course of the systemic amyloidosis described in the present study seems to parallel that described in man (4, 12) . Limited deposits of amyloid are found frequently in aged humans, but the prognosis for systemic amyloidosis is unfavorable (4, 12) . Part of the problem in determining or evaluating treatment for systemic amyloidosis in humans is the lack of a comparable experimental animal test system. The techniques described in the present study may therefore represent a model system for further studies of systemic amyloidosis.
